ATE213932T1 - Mittel mit gesteuerter freisetzung, die eine umgekehrte micellare (l2) struktur oder eine normale micellare (l1) struktur bilden - Google Patents

Mittel mit gesteuerter freisetzung, die eine umgekehrte micellare (l2) struktur oder eine normale micellare (l1) struktur bilden

Info

Publication number
ATE213932T1
ATE213932T1 AT95941306T AT95941306T ATE213932T1 AT E213932 T1 ATE213932 T1 AT E213932T1 AT 95941306 T AT95941306 T AT 95941306T AT 95941306 T AT95941306 T AT 95941306T AT E213932 T1 ATE213932 T1 AT E213932T1
Authority
AT
Austria
Prior art keywords
micellar
pct
mixture
composition
normal
Prior art date
Application number
AT95941306T
Other languages
English (en)
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Original Assignee
Camurus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camurus Ab filed Critical Camurus Ab
Application granted granted Critical
Publication of ATE213932T1 publication Critical patent/ATE213932T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Detergent Compositions (AREA)
AT95941306T 1994-12-09 1995-12-08 Mittel mit gesteuerter freisetzung, die eine umgekehrte micellare (l2) struktur oder eine normale micellare (l1) struktur bilden ATE213932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin
PCT/SE1995/001479 WO1996017597A1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure

Publications (1)

Publication Number Publication Date
ATE213932T1 true ATE213932T1 (de) 2002-03-15

Family

ID=20396276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941306T ATE213932T1 (de) 1994-12-09 1995-12-08 Mittel mit gesteuerter freisetzung, die eine umgekehrte micellare (l2) struktur oder eine normale micellare (l1) struktur bilden

Country Status (13)

Country Link
US (1) US5906831A (de)
EP (1) EP0790822B1 (de)
JP (1) JP3487860B2 (de)
AT (1) ATE213932T1 (de)
AU (1) AU4276896A (de)
BR (1) BR9509897A (de)
CA (1) CA2207218C (de)
DE (1) DE69525761T2 (de)
ES (1) ES2170171T3 (de)
FI (1) FI972415A7 (de)
NO (1) NO972614L (de)
SE (1) SE518619C2 (de)
WO (1) WO1996017597A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
WO2003039612A1 (en) 2001-11-08 2003-05-15 Atrium Medical Corporation Intraluminal device with a coating containing a therapeutic agent
EP1460992B1 (de) * 2001-12-03 2009-03-11 Dor Biopharma, Inc. Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US20060067977A1 (en) * 2004-09-28 2006-03-30 Atrium Medical Corporation Pre-dried drug delivery coating for use with a stent
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
EP1811933B1 (de) 2004-09-28 2016-03-23 Atrium Medical Corporation Barriereschicht
US20060083768A1 (en) * 2004-09-28 2006-04-20 Atrium Medical Corporation Method of thickening a coating using a drug
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
EP2083875B1 (de) 2006-11-06 2013-03-27 Atrium Medical Corporation Beschichtetes chirurgisches netz
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DK3085381T3 (en) * 2008-05-21 2018-05-28 Ferring Bv ORODISPERSIBLE DESMOPRESSIN TO INCREASE THE INITIAL PERIOD OF SLEEP UNDERSTANDED BY NEW TURRY
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN107709349B (zh) 2015-05-20 2022-01-28 阿比尔技术公司 植物提取物组合物和制备其的方法
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
ES2935595T3 (es) 2015-09-16 2023-03-08 Apeel Tech Inc Método de formación de un recubrimiento protector aplicando compuestos de glicéridos de ácidos grasos a una superficie
EP3386303B1 (de) 2015-12-10 2020-03-11 Apeel Technology, Inc. Verfahren zur depolymerisierung von cutin
EP3407713A1 (de) 2016-01-26 2018-12-05 Apeel Technology, Inc. Verfahren zur herstellung und konservierung von hygienisierten produkten
WO2018094269A1 (en) 2016-11-17 2018-05-24 Apeel Technology, Inc. Compositions formed from plant extracts and methods of preparation thereof
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
JP2021531348A (ja) 2018-07-20 2021-11-18 リポシン，インク． 肝臓病
US12245605B2 (en) 2018-09-05 2025-03-11 Apeel Technology, Inc. Compounds and formulations for protective coatings
MX2022010392A (es) 2020-03-04 2022-09-05 Apeel Tech Inc Productos agricolas recubiertos y metodos correspondientes.
MX2023004343A (es) 2020-10-30 2023-05-08 Apeel Tech Inc Composiciones y metodos de preparacion de las mismas.
BR112023006138A2 (pt) * 2020-11-04 2023-05-09 Inolex Investment Corp Composições de éster de heptanoato de glicerila de base biológica e métodos de preparação e uso das mesmas
WO2023039077A1 (en) 2021-09-08 2023-03-16 Apeel Technology, Inc. Compounds and formulations for protective coatings

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Also Published As

Publication number Publication date
JPH10510260A (ja) 1998-10-06
US5906831A (en) 1999-05-25
FI972415A0 (fi) 1997-06-06
CA2207218A1 (en) 1996-06-13
JP3487860B2 (ja) 2004-01-19
BR9509897A (pt) 1997-12-30
DE69525761T2 (de) 2002-10-24
SE518619C2 (sv) 2002-10-29
SE9404289L (sv) 1996-06-10
NO972614D0 (no) 1997-06-06
CA2207218C (en) 2002-02-12
ES2170171T3 (es) 2002-08-01
SE9404289D0 (sv) 1994-12-09
DE69525761D1 (de) 2002-04-11
AU4276896A (en) 1996-06-26
NO972614L (no) 1997-06-06
FI972415L (fi) 1997-06-06
EP0790822A1 (de) 1997-08-27
WO1996017597A1 (en) 1996-06-13
EP0790822B1 (de) 2002-03-06
FI972415A7 (fi) 1997-06-06

Similar Documents

Publication Publication Date Title
ATE213932T1 (de) Mittel mit gesteuerter freisetzung, die eine umgekehrte micellare (l2) struktur oder eine normale micellare (l1) struktur bilden
KR920016087A (ko) 진통제 조성물
KR870002830A (ko) 고농도-오일-함유 무수 발포성 조성물
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
DE59009034D1 (de) Desodorierende kosmetische mittel.
KR910000104A (ko) 투명 조성물
ATE99924T1 (de) Amphipatische emulgiermittel enthaltende emulsionzusammensetzungen.
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
ATE94757T1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
MX9500133A (es) Emulsiones de agua/aceite de alta fase interna.
DK0711115T3 (da) Smøremateriale med lavt fedtindhold.
KR880013472A (ko) 크리임상 유지조성물의 제조법
DE69410060D1 (de) Stabilisierte nahrungsmittelzusammensetzung
KR920016021A (ko) 동물의 발육 촉진 또는 개선 사료 및 방법
KR920009406A (ko) 화상 치료제
KR900001830A (ko) 트리폴리포스페이트를 함유하는 액상 세제의 제조방법
KR950016705A (ko) 여드름 예방 및 치료용 피부세정제 조성물
KR940001880A (ko) 죽염을 함유하는 피부세정제 조성물
KR950030851A (ko) 저지방 크리임 조성물
KR920007538A (ko) 벤푸레세이트 및 다임론을 기재로 하는 제초 조성물
KR910019933A (ko) 인축분뇨(人畜糞尿)의 무취무해 처리액 조성물
KR920019344A (ko) α-리놀렌산을 이용한 간장질환의 예방 및 치료 조성물
AR001341A1 (es) Composición coadyuvante líquida de uso agricola.
KR900001359A (ko) 피부미용 물비누 제조방법
KR960030935A (ko) 소버짐 치료용 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties